Logo

Oxford Molecular Debuts New Version of Assay and Screening Data System

Feb 25, 2000
Premium

H

UNT VALLEY, Md.--Oxford Molecular Group has launched OMMM 2.0, designed for use by biologists, pharmacologists, and research managers in the drug discovery screening environment. OMMM, the desktop-component of Oxford’s Oracle-based system for enterprisewide and smaller screening operations and workgroups, is a flexible tool that can be configured to meet specific lab needs, said the company. The new release has enhanced tools for data analysis and features to enable easier use and greater levels of automation and customization.

Filed under

Informatics
Breaking News
The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.